Financhill
Back

Xenon Pharmaceuticals Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
54

XENE
Xenon Pharmaceuticals

Last Price:
41.79
Seasonality Move:
14.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Xenon Pharmaceuticals Price Quote

$41.79
+0.09 (+0.24%)
(Updated: November 5, 2024 at 5:48 AM ET)

Xenon Pharmaceuticals Key Stats

Buy
54
Xenon Pharmaceuticals (XENE) is a Buy

Day range:
$41.29 - $42.44
52-week range:
$27.99 - $50.99
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
230.52
P/B ratio:
3.74%

Volume:
406K
Avg. volume:
345.1K
1-year change:
26.82%
Market cap:
$3.2B
Revenue:
$0
EPS:
$-2.74

How Much Does Xenon Pharmaceuticals Make?

Data Unavailable

Is Xenon Pharmaceuticals Growing As A Company?

Data Unavailable

Xenon Pharmaceuticals Stock Price Performance

What Is Xenon Pharmaceuticals 52-Week High & Low?

Xenon Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Xenon Pharmaceuticals?

Is Xenon Pharmaceuticals Cash Flow Positive?

  • What Is XENE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$153.6M
  • What Is Xenon Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Xenon Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$127.2M

Xenon Pharmaceuticals Return On Invested Capital

Data Unavailable

Xenon Pharmaceuticals Earnings Date & Stock Price

Xenon Pharmaceuticals Competitors

Xenon Pharmaceuticals Dividend Yield

Xenon Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -10.65%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 57.27
Upside from Last Price: 37.33%

Major Shareholders

  • How many XENE shares are owned by institutional investors?
    124.9M XENE shares are owned by institutional investors
  • How many XENE shares are owned by insiders?
    542.8K XENE shares are owned by insiders